Is CRISPR Therapeutics AG technically bullish or bearish?

As of 31 October 2025, the technical trend for CRISPR Therapeutics AG has changed from mildly bullish to bullish. The weekly MACD is bullish, and the daily moving averages are also bullish, indicating strong upward momentum. However, the KST and Dow Theory on a weekly basis show mildly bearish signals, which suggests some caution is warranted. The stock has underperformed the S&P 500 over the past week and month, with returns of -5.35% and -3.28%, respectively, compared to the S&P 500's gains of 0.71% and 1.92%. Despite this recent weakness, the year-to-date return of 62.58% significantly outperforms the S&P 500's 16.30%, indicating strong longer-term performance. Overall, the current stance is bullish, with strength primarily driven by the daily moving averages and weekly MACD.